Heavily Shorted Intrexon Stock Sinks Before Earnings

 | Feb 28, 2019 11:51PM ET

Biotechnology name Intrexon Corp. (NASDAQ:XON) is slated to report fourth-quarter earnings after the market closes this afternoon. Below we will dive into the stock's chart performance, and look at what the options market is pricing in for XON for tomorrow's trading.

Ahead of the report, XON is down 3.7% at $7.97, though it remains comfortably above its 50-day moving average. Specifically, Intrexon stock broke above this trendline two weeks ago, and has since brought its year-to-date gain to 21.1%. This pales in comparison to a wider view of the stock, which is staring at a year-over-year deficit of 39%.